PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
67.24%
Net income growth above 1.5x MCHP's 4.33%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-16.67%
Both reduce yoy D&A, with MCHP at -5.85%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
6.25%
Lower deferred tax growth vs. MCHP's 162.58%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
21.12%
Less working capital growth vs. MCHP's 60.85%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
-111.41%
Negative yoy inventory while MCHP is 92.41%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
64.52%
Growth well above MCHP's 51.15%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-96.42%
Both negative yoy, with MCHP at -88.43%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-62.05%
Negative yoy CFO while MCHP is 188.45%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
49.15%
CapEx growth well above MCHP's 65.74%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
37.20%
Purchases growth of 37.20% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-33.69%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
47.66%
Investing outflow well above MCHP's 68.66%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-66.67%
Both yoy lines negative, with MCHP at -95.02%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
1.18%
Buyback growth of 1.18% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.